Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era.

ABSTRACT:

Background

Hepatitis C virus (HCV) remains under-treated in the United States and treatment by nonspecialist providers can expand access. We compare HCV treatment provision and treatment completion between nonspecialist and specialist providers.

Methods

This retrospective study used claims data from the Healthcare Cost Institute from 2013 to 2017. We identified providers who prescribed HCV therapy between 2013 and 2017, and patients enrolled in private insurance or Medicare Advantage who had pharmacy claims for HCV treatment. We measured HCV treatment completion, determined based on prescription fills for the minimum expected duration of the antiviral regimen. Using propensity score-weighted regression, we compared the likelihood of early treatment discontinuation by the typ

SUBMITTER: Kapadia SN 

PROVIDER: S-EPMC8384709 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature